![]() |
![]() |
Korean J Helicobacter Up Gastrointest Res > Volume 25(2); 2025 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Conflicts of Interest
Yong Hwan Kwon, a contributing editor of the Korean Journal of Helicobacter and Upper Gastrointestinal Research, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
Funding Statement
This work has supported by the Korean College of Helicobacter and Upper Gastrointestinal Research Foundation Grant (Grant Number, KCHUGR-202201003).
Authors’ Contribution
Conceptualization: Seong Woo Jeon. Data curation: Sang Un Kim. Formal analysis: Ji Hye Park. Funding acquisition: Seong Woo Jeon. Investigation: Ji Hye Park, Seong Woo Jeon, Sang Un Kim. Methodology: Ji Hye Park, Yong Hwan Kwon, Joon Hyun Cho, June Hwa Bae. Project administration: Seong Woo Jeon. Supervision: Seong Woo Jeon. Validation: Seong Woo Jeon. Visualization: Ji Hye Park, Jeong Hwa Lee. Writing—original draft: Jeong Hwa Lee, Seong Woo Jeon. Writing—review & editing: Joon Hyun Cho, June Hwa Bae, Seong Woo Jeon. Approval of final manuscript: all authors.
MIC | Antibiotics | Number of resistant samples (n=73) | Resistance rate (%) |
---|---|---|---|
(R:>0.125) | AMO | 20 | 27 |
(R:>0.25) | CLA | 25 | 34 |
(R:>8) | MTZ | 34 | 47 |
(R:>1) | TC | 19 | 26 |
(R:>1) | LEVO | 27 | 37 |
Modified from Gong and Ahn. Korean J Helicobacter Up Gastrointest Res 2018;18:82-88.7, under the terms of the Creative Commons (CC BY-NC) License and Lee. Korean J Helicobacter Up Gastrointest Res 2022;22:83-85.15, under the terms of the Creative Commons (CC BY-NC) License.
AMO, amoxicillin; CLA, clarithromycin; MTZ, metronidazole; TC, tetracycline; LEVO, levofloxacin.
Simplified Eradication of Helicobacter pylori for Patients With Penicillin-Allergy2025 March;25(1)
Prevention of Gastric Cancer: Helicobacter pylori Treatment2024 September;24(3)
What Is the Optimal Drug Regimen for Helicobacter pylori Eradication Therapy?2024 June;24(2)
![]() |
![]() |